For example, pre-clinical models have demonstrated the superior therapeutic efficacy of intraventricular injection of CAR-T cells targeting HER2 and IL13Rα2 in breast cancer brain metastases and glioblastoma, respectively (261, 262). This evidence concerns the gene ERBB2 and glioblastoma.